pioglitazone has been researched along with Cryptococcosis in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Cryptococcosis: Fungal infection caused by genus CRYPTOCOCCUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pioglitazone (PIO) is a peroxisome proliferator-activated receptor-γ agonist widely repositioned as an adjuvant of various drugs that have toxic effects due to its antioxidant and anti-inflammatory effects." | 5.51 | Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis. ( Carmo, PHF; Costa, MC; de Brito, CB; de Souza, DG; Emídio, ECP; Freitas, GJC; Paixão, TA; Ribeiro, NQ; Santos, APN; Santos, DA; Silva, MF, 2019) |
| "Pioglitazone (PIO) is a peroxisome proliferator-activated receptor-γ agonist widely repositioned as an adjuvant of various drugs that have toxic effects due to its antioxidant and anti-inflammatory effects." | 1.51 | Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis. ( Carmo, PHF; Costa, MC; de Brito, CB; de Souza, DG; Emídio, ECP; Freitas, GJC; Paixão, TA; Ribeiro, NQ; Santos, APN; Santos, DA; Silva, MF, 2019) |
| "Cryptococcosis is an opportunistic infection caused by Cryptococcus neoformans that typically presents in immunocompromised patients, most commonly in those with human immunodeficiency virus (HIV) infection." | 1.40 | Disseminated cryptococcosis in a diabetic patient. ( Khatu, S; Poojary, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ribeiro, NQ | 1 |
| Santos, APN | 1 |
| Emídio, ECP | 1 |
| Costa, MC | 1 |
| Freitas, GJC | 1 |
| Carmo, PHF | 1 |
| Silva, MF | 1 |
| de Brito, CB | 1 |
| de Souza, DG | 1 |
| Paixão, TA | 1 |
| Santos, DA | 1 |
| Poojary, S | 1 |
| Khatu, S | 1 |
2 other studies available for pioglitazone and Cryptococcosis
| Article | Year |
|---|---|
Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antioxidants; Cryptococcosis; Cryptococcus gattii; Disea | 2019 |
Disseminated cryptococcosis in a diabetic patient.
Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diabetes Mellitus, | 2014 |